A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| PSMα3 | PSMα3 is a peptide for manipulating DCs to become tolerogenic for DC vaccination strategies. PSMα3 penetrates and modulates human monocyte-derived DCs by altering the TLR2- or TLR4-induced maturation, inhibiting pro- and anti-inflammatory cytokine production and reducing antigen uptake. PSMα3 is an important toxin released by the most virulent strains of methicillin-resistant Staphylococcus aureus (MRSA) [1] [2]. Uses: Scientific research. Group: Peptides. CAS No. 1001405-52-2. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P2358. |  |
| PSMA-PEG4 | Synonyms: (21S,25S)-1-Amino-15,23-dioxo-3,6,9,12-tetraoxa-16,22,24-triazaheptacosane-21,25,27-tricarboxylic acid. CAS No. 2256069-92-6. Molecular formula: C23H42N4O12. Mole weight: 566.60. |  |
| PSMA/PSM-P1 (4-12) | This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of PSMA-derived peptide of LLHETDSAV sequence covering 4-12 and A*0201 molecule. | |
| PSM P2 (711-719) | PSM P2 (711-719) is a 9-aa peptide. PSM P2 is a zinc metalloenzyme that resides in membranes. It is mainly expressed in four tissues of the body, including prostate epithelium, the proximal tubules of the kidney, the jejunal brush border of the small intestine and ganglia of the nervous system. Synonyms: Glutamate carboxypeptidase 2 (711-719); N-acetyl-L-aspartyl-L-glutamate peptidase I (711-719); NAAG peptidase (711-719); prostate-specific membrane antigen (PSMA) (711-719). | |
| PSN 375963 | PSN 375963 is a potent GPR119 agonist, with EC 50 s of 8.4 and 7.9 μM for human and mouse GPR119, respectively. PSN 375963 shows similar potency to the endogenous agonist oleoylethanolamide (OEA) [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 388575-52-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-108258. | |
| PSN-375963 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| PSN 375963 hydrochloride | PSN 375963 is a potent and selective agonist of GPR119 (EC50= 8.4 and 7.9 μM at human and mouse receptors respectively), which shows similar potency to oleoyl ethanolamide (OEA) at both recombinant mouse and human GPR119 receptors. PSN375963 may be useful as a therapeutic agent for the treatment of obesity. Synonyms: PSN375963; PSN 375963; PSN-375963; 4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridine hydrochloride. Grades: ≥98% by HPLC. CAS No. 388575-52-8. Molecular formula: C17H23N3O.HCl. Mole weight: 321.84. | |
| PSN 375963 hydrochloride | PSN 375963 hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 388575-52-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| PSN632408 | PSN632408 is an optimized agonist of GPR119 receptors that shows similar potency to OEA at both recombinant mouse and human GPR119 receptors. It suppresses food intake, reduces weight gain, and white adipose tissue deposition in rats. It may be useful as a therapeutic agent for the treatment of obesity. Synonyms: PSN632408; PSN 632408; PSN-632408. Grades: >98%. CAS No. 857652-30-3. Molecular formula: C18H24N4O4. Mole weight: 360.41. | |
| PSNCBAM-1 | PSNCBAM-1 is a selective CB1 receptor allosteric antagonist with an EC 50 of 0.1 μM. PSNCBAM-1 can be used in the researches of obesity [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 877202-74-9. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-110179. | |
| PSNCBAM-1 | PSNCBAM-1 is an allosteric, non-competitive antagonist of CB-1 (IC50= 45 and 209 nM) with hypophagic effects in vivo, potentially an anti-obesity agents. Synonyms: N-(4-Chlorophenyl)-N'-[3-[6-(1-pyrrolidinyl)-2-pyridinyl]phenyl]urea; PSNCBAM-1; PSNCBAM 1; PSNCBAM1. Grades: ≥99% by HPLC. CAS No. 877202-74-9. Molecular formula: C22H21ClN4O. Mole weight: 392.88. | |
| PSNCBAM-1 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Psora 4 | Psora 4. Group: Biochemicals. Grades: Purified. CAS No. 724709-68-6. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Psora 4 | Psora 4 is the most potent small-molecule Kv1.3 blocker known. It blocked Kv1.3 in a use-dependent manner, with a Hill coefficient of 2 and an EC50value of 3 nM, by preferentially binding to the C-type inactivated state of the channel. Synonyms: 4-(4-Phenylbutoxy)-7H-furo[3,2-g][1]benzopyran-7-one. Grades: ≥99% by HPLC. CAS No. 724709-68-6. Molecular formula: C21H18O4. Mole weight: 334.37. | |
| Psora-4 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Psoralen | Psoralen (Ficusin) is a coumarin isolated from the seeds of Fructus Psoraleae. Psoralen exhibits a wide range of biological properties, including anti-cancer, antioxidant, antidepressant, anticancer, antibacterial, and antiviral, et al [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Ficusin. CAS No. 66-97-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-N0053. | |
| Psoralen | Psoralen (Ficusin) is a coumarin isolated from the seeds of Fructus Psoraleae. Psoralen exhibits a wide range of biological properties, including anti-cancer, antioxidant, antidepressant, anticancer, antibacterial, and antiviral, et al. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2-Propenoicacid,3-(6-hydroxy-5-benzofuranyl)-,δ-lactone. Product Category: Inhibitors. Appearance: White powder. CAS No. 66-97-7. Molecular formula: C11H6O3. Mole weight: 186.16. Purity: 0.98. IUPACName: Furo[3,2-g]chromen-7-one. Canonical SMILES: C1=CC(=O)OC2=CC3=C(C=CO3)C=C21. Density: 1.25 g/ml. Product ID: ACM66977. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Psoralen | Psoralen. Group: Biochemicals. Grades: Highly Purified. CAS No. 66-97-7. Pack Sizes: 10mg, 25mg, 50mg, 100mg. Molecular Formula: C11H6O3. US Biological Life Sciences. | Worldwide |
| Psoralen (7H-Furo[3,2-g][1]benzopyran-7-one, Furo[3,2-g]coumarin, Ficusin) | Psoralens are phytoalexins; they are used by plants in a defensive response to attacks by fungi and insects. They have also shown photosensitizing and phototoxic effects in animals and humans and have been used in photochemotherapy for management of vitiligo, psoriasis, and mycosis fungoides. Used as photochemical probe in biological systems. Group: Biochemicals. Alternative Names: 7H-Furo[3,2-g][1]benzopyran-7-one; Furo[3,2-g]coumarin; Ficusin. Grades: Highly Purified. CAS No. 66-97-7. Pack Sizes: 10mg, 25mg, 50mg, 100mg. Molecular Formula: C11H6O3. US Biological Life Sciences. | Worldwide |
| Psoralen Azide | Psoralen Azide is a chemical compound used in biomedical research to study DNA damage and repair pathways. It is commonly used to crosslink DNA and proteins, as well as to label proteins with azide groups for subsequent click chemistry reactions. Synonyms: 4'-Azidomethyl-4,5',8-trimethylpsoralen. Molecular formula: C15H13N3O3. Mole weight: 283.28. | |
| Psoralen-C2 CEP | Psoralen-C2 CEP is an innovative biomedical compound, used for studying a myriad of skin afflictions, particularly psoriasand vitiligo. It is derived from psoralen, an organic constituent inherent to select flora. Synonyms: 2-[4'-(hydroxymethyl)-4,5',8-trimethylpsoralen]-ethyl-1-O-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramidite; Psoralen C2 Phosphoramidite. Grades: 95%. CAS No. 126221-83-8. Molecular formula: C26H35N2O6P. Mole weight: 502.55. | |
| Psoralen C6 Phosphoramidite | Psoralen C6 Phosphoramidite is an indispensable compound, finding extensive employment in DNA synthesis and modification. This remarkable product effectively facilitates the incorporation of psoralen derivatives into oligonucleotides, thereby enabling the research of an extensive array of afflictions encompassing cancer and dermatological conditions. Synonyms: 6-[4'-(Hydroxymethyl)-4,5',8-trimethylpsoralen]-hexyl-1-O-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramidite; Phosphoramidous acid, N,N-bis(1-methylethyl)-, 2-cyanoethyl6-[(2,5,9-trimethyl-7-oxo-7H-furo[3,2-g][1]benzopyran-3-yl)methoxy]hexyl ester. CAS No. 518046-08-7. Molecular formula: C30H43N2O6P. Mole weight: 558.65. | |
| psoralen synthase | This microsomal cytochrome P-450-dependent enzyme is specific for (+)-marmesin, and to a much lesser extent 5-hydroxymarmesin, as substrate. Furanocoumarins protect plants from fungal invasion and herbivore attack. (+)-Columbianetin, the angular furanocoumarin analogue of the linear furanocoumarin (+)-marmesin, is not a substrate for the enzyme but it is a competitive inhibitor. Group: Enzymes. Synonyms: CYP71AJ1. Enzyme Commission Number: EC 1.14.13.102. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-0701; psoralen synthase; EC 1.14.13.102; CYP71AJ1. Cat No: EXWM-0701. |  |
| Psoralidin | Psoralidin is a dual inhibitor of COX-2 and 5-LOX , regulates ionizing radiation (IR)-induced pulmonary inflammation.Anti-cancer, anti-bacterial, and anti-inflammatory properties [1]. Psoralidin significantly downregulates NOTCH1 signaling. Psoralidin also greatly induces ROS generation [2]. Uses: Scientific research. Group: Natural products. CAS No. 18642-23-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg. Product ID: HY-N0232. | |
| Psoralidin | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Psoralidin | Psoralidin. Group: Biochemicals. Grades: Plant Grade. CAS No. 18642-23-4. Pack Sizes: 20mg. Molecular Formula: C20H16O5, Molecular Weight: 336.34. US Biological Life Sciences. | Worldwide |
| Psoromic acid | Psoromic acid is a potent and selective RabGGTase (Rab geranylgeranyl transferase) inhibitor with an IC 50 value of 1.3 μM. Psoromic acid is an antioxidative agent. Psoromic acid exhibits a competitive type of HMGR inhibition and mixed type of ACE (angiotensin converting enzyme) inhibition [1] [2]. Uses: Scientific research. Group: Natural products. Alternative Names: Parellic acid. CAS No. 7299-11-8. Pack Sizes: 500 μg. Product ID: HY-130199. | |
| Psoromic acid | Psoromic acid is a selective inhibitor of Rab geranylgeranyl transferase and P. falciparum fatty acid synthesis (FAS) II enzymes. Synonyms: 10-formyl-9-hydroxy-3-methoxy-4,7-dimethyl-6-oxobenzo[b][1,4]benzodioxepine-1-carboxylic acid; NSC 92186; Parellic Acid; Psoromsaeure; Sulcatic acid; Sqamaric. Grades: ≥95%. CAS No. 7299-11-8. Molecular formula: C18H14O8. Mole weight: 358.30. | |
| Psp124B I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA (HindIII-digest) in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 20-fold overdigestion with enzyme more than 90% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 1000U; 5000U. GAGCT↑C C↓TCGAG. Activity: 20000u.a./ml. Appearance: 10 X SE-buffer G. Storage: -20°C. Form: Liquid. Source: Pseudomonas species 124B. Pack: 10 mM Tris-HCl (pH 7.5); 250 mM NaCl; 0,1 mM EDTA; 7 mM 2-mercaptoethanol; 100 μg/ml BSA; 50% glycerol. Cat No: ET-1151RE. | |
| Psp6 I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA (dcm-) in 1 hour at 55°C in a total reaction volume of 50 μl. Applications: After 3-fold overdigestion with enzyme 95% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 100U; 500U. ↑CCWGG GGWCC&darr. Activity: 1000-3000u.a./ml. Appearance: 10 X SE-buffer B. Storage: -20°C. Form: Liquid. Source: Pseudomonas species 6. Pack: 10 mM Tris-HCl (pH 7.5); 100 mM KCl; 0.1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA; and 50% glycerol. Cat No: ET-1152RE. | |
| PS:PC (20:80)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. |  |
| PS:PC (30:70)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC (40:60)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC (50:50)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC (60:40)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC (70:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC (80:20)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC (90:10)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (10:55:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (1:64:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (20:45:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (2.5:62.5:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (30:35:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (40:25:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (50:15:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (5:60:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PS:PC:Chol:PEG2000 (60:5:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| PspC I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 20-fold overdigestion with enzyme more than 90% of the dna fragments can be ligated and recut. ligation is better in presence of 10% peg. Group: Restriction Enzymes. Purity: 2000U; 10000U. CAC↑GTG GTG↓CAC. Activity: 20000u.a./ml. Appearance: 10 X SE-buffer B, BSA. Storage: -20°C. Storage at -70°C is recommended for periods longer than 30 days. Form: Liquid. Source: Pseudomonas species C. Pack: 10 mM Tris-HCl (pH 7.5); 50 mM KCl; 0.1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA; and 50% glycerol. Cat No: ET-1153RE. | |
| PspE I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 10-fold overdigestion with enzyme more than 90% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 2000U; 10000U. G↑GTNACC CCANTG↓G. Activity: 10000u.a./ml. Appearance: 10 X SE-buffer B. Storage: -20°C. Form: Liquid. Source: Pseudomonas species E. Pack: 10 mM Tris-HCl (pH 7.5); 50 mM NaCl; 0,1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA; 50% glycerol. Cat No: ET-1154RE. | |
| PspL I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA (HindIII-digest) in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 2-fold overdigestion with enzyme more than 95% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 200U; 1000U. C↑GTACG GCATG↓C. Activity: 2000-5000u.a./ml. Appearance: 10 X SE-buffer Y, BSA. Storage: -20°C. Form: Liquid. Source: Pseudomonas species L. Pack: 10 mM Tris-HCl (pH 7.5); 100 mM NaCl; 0.1 mM EDTA; 7 mM 2-mercaptoethanol; 100 μg/ml BSA; 50% glycerol. Cat No: ET-1155RE. | |
| PspN4 I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 10-fold overdigestion with enzyme more than 95% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 1000U; 5000U. GGN↑NCC CCN↓NGG. Activity: 10000u.a./ml. Appearance: 10 X SE-buffer Y. Storage: -20°C. Form: Liquid. Source: Pseudomonas species N4. Pack: 10 mM Tris-HCl (pH 7.5); 50 mM KCl; 0,1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA; 50% glycerol. Cat No: ET-1156RE. | |
| PspOM I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA (BamHI-digest) in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 10-fold overdigestion with enzyme more than 95% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 1500U; 7500U. G↑GGCCC CCCGG↓G. Activity: 10000u.a./ml. Appearance: 10 X SE-buffer Y. Storage: -20°C. Form: Liquid. Source: An E.coli strain that carries the cloned PspOM I gene from Pseudomonas species OM2164. Pack: 20 mM Tris-HCl (pH 7.5); 50 mM NaCl; 0,1 mM EDTA; 1 mM DTT; 200 μg/ml BSA; and 50% glycerol. Cat No: ET-1157RE. | |
| PspPP I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA/HindIII in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 5-fold overdigestion with enzyme more than 70% of the dna fragments can be ligated and more than 80% of these can be recut. Group: Restriction Enzymes. Purity: 100U; 500U. RG↑GWCCY YCCWG↓GR. Activity: 2000-5000u.a./ml. Appearance: 10 X SE-buffer Y, BSA. Storage: -20°C. Form: Liquid. Source: Pseudomonas species PP. Pack: 10 mM Tris-HCl (pH 7.5); 200 mM NaCl; 0.1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA; 50% glycerol. Cat No: ET-1158RE. | |
| PspX I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA (HindIII-digest) in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 20-fold overdigestion with enzyme more than 90% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 200U; 1000U. VC↑TCGAGB BGAGCT↓CV. Activity: 10000u.a./ml. Appearance: 10 X SE-buffer Y, BSA. Storage: -20°C. Form: Liquid. Source: An E.coli strain that carries the cloned PspX I gene from Pseudomonas species A1-1. Pack: 10 mM Tris-HCl (pH 7.5); 200 mM KCl; 0.1 mM EDTA; 7 mM 2 -mercaptoethanol, 200 μg/ml BSA; 50% glycerol. Cat No: ET-1159RE. | |
| Psr I | One unit of the enzyme is the amount required to hydrolyze 1 μg of T7 DNA in 1 hour at 30°C in a total reaction volume of 50 μl. Applications: After 2-fold overdigestion with enzyme more than 70% of dna fragments can be ligated. of these 80% can be recut. in the presence of 10% peg ligation is better. Group: Restriction Enzymes. Purity: 100U; 500U. ↑(N)7GAACNNNNNNTAC(N)12↑ ↓(N)12CTTGNNNNNNATG(N)7&darr. Activity: 1000-2000u.a./ml. Appearance: 10 X SE-buffer Y, BSA. Storage: -20°C. Form: Liquid. Source: Pseudomonas stutzeri N2. Pack: 10 mM Tris-HCl (pH 7.5); 50 mM KCl; 0,1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA, 50% glycerol. Cat No: ET-1160RE. | |
| Pss-(1-propylmethacrylate)-heptaisobuty& | Pss-(1-propylmethacrylate)-heptaisobuty&. Group: Poss nanohybrid materials. Alternative Names: PSS-(1-PROPYLMETHACRYLATE)-HEPTAISOBUTY&; 3-(3, 5, -HEPTAISOBUTYLPENTACYCLO(9.5(3, 9); 3-(3, 5, 7, 9, 11, 13, 15-heptaisobutylpentacyclo[9.5.13, 9.15, 15.17, 13]octasiloxan-1-yl)propylmethacrylate; pss-(1-propylmethacrylate)-heptaisobutyl substituted; METHACRYLOXYPROPYL. CAS No. 307531-94-8. Product ID: 3-[3, 5, 7, 9, 11, 13, 15-heptakis(2-methylpropyl)-2, 4, 6, 8, 10, 12, 14, 16, 17, 18, 19, 20-dodecaoxa-1, 3, 5, 7, 9, 11, 13, 15-octasilapentacyclo[9.5.1.13, 9.15, 15.17, 13]icosan-1-yl]propyl 2-methylprop-2-enoate. Molecular formula: 943.6g/mol. Mole weight: C35H74O14Si8. CC (C)C[Si]12O[Si]3 (O[Si]4 (O[Si] (O1) (O[Si]5 (O[Si] (O2) (O[Si] (O3) (O[Si] (O4) (O5)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CCCOC (=O)C (=C)C. InChI=1S/C35H74O14Si8/c1-27 (2)20-51-38-50 (19-17-18-37-35 (36)34 (15)16)39-52 (21-28 (3)4)43-54 (41-51, 23-30 (7)8)47-57 (26-33 (13)14)48-55 (42-51, 24-31 (9)10)44-53 (40-50, 22-29 (5)6)46-56 (45-52, 49-57)25-32 (11)12/h27-33H, 15, 17-26H2, 1-14, 16H3. CVYLJMBNVJQTGW-UHFFFAOYSA-N. |  |
| Pss-(2-(3 4-epoxycyclohexyl)ethyl)-hept& | Pss-(2-(3 4-epoxycyclohexyl)ethyl)-hept&. Group: Poss nanohybrid materials. Alternative Names: PSS-(2-(3 4-EPOXYCYCLOHEXYL)ETHYL)-HEPT&; 1-(2-(3,4-EPOXYCYCLOHEXYL)ETHYL-3,5,7,9,11 -ISOBUTYLPENTACYCLO-(9. 5. )OCTASILOXAN; 1-[2-(3, 4-epoxycyclohexyl)ethyl]-3, 5, 7, 9, 11, 13, 15-isobutylpentacyclo-[9.5.1.13, 9.15, 15.17, 13]octasiloxane; pss-[2-(3,4-epoxycyclohexyl. CAS No. 445379-56-6. Product ID: AC1MW6NE. Molecular formula: 957.67. Mole weight: C36< / sub>H76< / sub>O14< / sub>Si8< / sub>. 96%. | |
| Pss-(2 3-propanediol)propoxy-heptaisobu& | Pss-(2 3-propanediol)propoxy-heptaisobu&. Group: Poss nanohybrid materials. Alternative Names: PSS-(2 3-PROPANEDIOL)PROPOXY-HEPTAISOBU&; 1-(2,3-PROPANEDIOL)PROPOXY-3,5,7,9,11,13, 15-ISOBUTYLPENTACYCLO-(9.5.)OCTASILOXA; pss-(2,3-propanediol)propoxy-heptaisobutyl substituted; 1,2-Propanediolisobutyl-POSS(R),POSS(R)-1,2-propanediol-isobutylsubstituted,1-. CAS No. 480439-49-4. Product ID: AC1N8M4T. Molecular formula: 965.646. Mole weight: C34< / sub>H76< / sub>O16< / sub>Si8< / sub>. CC (C)C[Si]12O[Si]3 (O[Si]4 (O[Si] (O1) (O[Si]5 (O[Si] (O2) (O[Si] (O3) (O[Si] (O4) (O5)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CCCOCC (CO)O. DXYPXQNYEYJHJT-UHFFFAOYSA-N. 96%. | |
| Pss-[2-[ (Chloromethyl) Phenyl]Ethyl]-Heptaisobutyl Substituted | Pss-[2-[ (Chloromethyl) Phenyl]Ethyl]-Heptaisobutyl Substituted. Group: Poss nanohybrid materials. Alternative Names: 1-Chlorobenzylethyl-3, 5, 7, 9, 11, 13, 15-Heptaisobutylpentacyclo[9.5.1.1(3, 9).1(5, 15).1(7, 13)]Ctasiloxane. Pack Sizes: 5 g. Molecular formula: 970.11 g/mol. Mole weight: C37H73ClO12Si8. | |
| PSS-[2-[(Chloromethyl)phenyl]ethyl]-Heptaisobutyl substituted | 97%. Group: Silsesquioxanes: poss nanohybrids. | |
| Pss-(2-(trans-3 4-cyclohexanediol)ethyl | Pss-(2-(trans-3 4-cyclohexanediol)ethyl Group: Poss nanohybrid materials. Alternative Names: PSS-(2-(TRANS-3 4-CYCLOHEXANEDIOL)ETHYL ; 1-(2-TRANS-CYCLOHEXANEDIOL)ETHYL-3,5,7,9, 15-ISOBUTYLPENTACYCLO-OCTASILOXANE; 1-(2-trans-cyclohexanediol)ethyl-3,5,7,9,11,13,15-isobutylpentacyclo-[9.5.1.13,9.15,15.17,13]octasiloxane; pss-(2-(trans-3,4-cyclohexaned. CAS No. 480439-48-3. Product ID: AC1MUI3F. Molecular formula: 975.685. Mole weight: C36< / sub>H78< / sub>O15< / sub>Si8< / sub>. 96%. | |
| Pss-(3-(2-aminoethyl)amino)propyl-hepta& | Pss-(3-(2-aminoethyl)amino)propyl-hepta&. Group: Poss nanohybrid materials. Alternative Names: PSS-(3-(2-AMINOETHYL)AMINO)PROPYL-HEPTA&; 1-(3-(2-AMINOETHYL)AMINO)PROPYL-3,5,7,9,11 -ISOBUTYLPENTACYCLO-(9. 5. )OCTASILOXAN; 1-[3-(2-aminoethyl)amino]propyl-3, 5, 7, 9, 11, 13, 15-isobutylpentacyclo-[9.5.1.1(3, 9).1(5, 15).1(7, 13)]octasiloxane; pss-[3-(2-aminoethyl)a. CAS No. 444315-16-6. Product ID: AC1NCUKU. Molecular formula: 917.653. Mole weight: C33< / sub>H76< / sub>N2< / sub>O12< / sub>Si8< / sub>. CC (C)C[Si]12O[Si]3 (O[Si]4 (O[Si] (O1) (O[Si]5 (O[Si] (O2) (O[Si] (O3) (O[Si] (O4) (O5)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CCCNCCN. KHYRGQGGJMEVTP-UHFFFAOYSA-N. 96%. | |
| Pss-(3-cyclohexen-1-yl)-heptacyclopenty& | Pss-(3-cyclohexen-1-yl)-heptacyclopenty&. Uses: Designed for use in research and industrial production. Additional or Alternative Names: PSS-(3-CYCLOHEXEN-1-YL)-HEPTACYCLOPENTY&;1-(3-cyclohexen-1-yl)-3,5,7,9,11,13,15-heptacyclopentylpentacyclo[9.5.1.13,9.15,15.17,13]octasiloxane;pss-(3-cyclohexen-1-yl)-heptacyclopentyl substituted;Cyclohexenyl-POSS(R),1-(3-Cyclohexen-1-yl)-3,5,7,9,11,13,15. Product Category: Nanoparticles & Nanopowders. CAS No. 307496-29-3. Molecular formula: C41H72O12Si8. Mole weight: 981.696. Product ID: ACM307496293. Alfa Chemistry ISO 9001:2015 Certified. | |
| Pss-(3-glycidyl)propoxy-heptaisobutyl s& | Pss-(3-glycidyl)propoxy-heptaisobutyl s&. Group: Poss nanohybrid materials. Alternative Names: PSS-(3-GLYCIDYL)PROPOXY-HEPTAISOBUTYL S&; 1-(3-GLYCIDYL)PROPOXY-3, 5, 7, 9, 11, 13, 15-ISOBUTYLPENTACYCLO-(9. 5. )OCTASILOXANE; pss-(3-glycidyl)propoxy-heptaisobutyl substituted; Glycidylisobutyl-POSS(R),POSS(R)-Glycidyl-isobutylsubstituted,1-(3-Glycidyl)propoxy-3,5. CAS No. 444315-17-7. Product ID: 1, 3, 5, 7, 9, 11, 13-heptakis(2-methylpropyl)-15-[3-(oxiran-2-ylmethoxy)propyl]-2, 4, 6, 8, 10, 12, 14, 16, 17, 18, 19, 20-dodecaoxa-1, 3, 5, 7, 9, 11, 13, 15-octasilapentacyclo[9.5.1.13, 9.15, 15.17, 13]icosane. Molecular formula: 931.6g/mol. Mole weight: C34H74O14Si8. CC (C)C[Si]12O[Si]3 (O[Si]4 (O[Si] (O1) (O[Si]5 (O[Si] (O2) (O[Si] (O3) (O[Si] (O4) (O5)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CCCOCC6CO6. InChI=1S/C34H74O14Si8/c1-27 (2)20-50-37-49 (17-15-16-35-18-34-19-36-34)38-51 (21-28 (3)4)42-53 (40-50, 23-30 (7)8)46-56 (26-33 (13)14)47-54 (41-50, 24-31 (9)10)43-52 (39-49, 22-29 (5)6)45-55 (44-51, 48-56)25-32 (11)12/h27-34H, 15-26H2, 1-14H3. GYEWKQMKBZAVJX-UHFFFAOYSA-N. | |
| PSS-(3-Hydroxypropyl)-heptaisobutyl substituted | PSS-(3-Hydroxypropyl)-heptaisobutyl substituted. Group: Poss nanohybrid materials. Product ID: 3-[3, 5, 7, 9, 11, 13, 15-heptakis(2-methylpropyl)-2, 4, 6, 8, 10, 12, 14, 16, 17, 18, 19, 20-dodecaoxa-1, 3, 5, 7, 9, 11, 13, 15-octasilapentacyclo[9.5.1.13, 9.15, 15.17, 13]icosan-1-yl]propan-1-ol. Molecular formula: 875.6g/mol. Mole weight: C31H70O13Si8. CC (C)C[Si]12O[Si]3 (O[Si]4 (O[Si] (O1) (O[Si]5 (O[Si] (O2) (O[Si] (O3) (O[Si] (O4) (O5)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CCCO. InChI=1S/C31H70O13Si8/c1-25 (2)18-46-33-45 (17-15-16-32)34-47 (19-26 (3)4)38-49 (36-46, 21-28 (7)8)42-52 (24-31 (13)14)43-50 (37-46, 22-29 (9)10)39-48 (35-45, 20-27 (5)6)41-51 (40-47, 44-52)23-30 (11)12/h25-32H, 15-24H2, 1-14H3. KHIWQVOGMPGXTC-UHFFFAOYSA-N. | |
| Pss-(3-mercapto)propyl-heptaisobutyl su& | Pss-(3-mercapto)propyl-heptaisobutyl su&. Group: Poss nanohybrid materials. Alternative Names: PSS-(3-MERCAPTO)PROPYL-HEPTAISOBUTYL SU&; 1-(3-MERCAPTO)PROPYL-3,5,7,9,11,13,15-ISO BUTYLPENTACYCLO-OCTASILOXANE; pss-(3-mercapto)propyl-heptaisobutyl substituted; Mercaptopropylisobutyl-POSS(R),POSS(R)-Mercaptopropyl-isobutylsubstituted,1-(3-Mercapto)propyl. CAS No. 480438-85-5. Product ID: AC1N7LY5. Molecular formula: 891.636. Mole weight: C31< / sub>H70< / sub>O12< / sub>SSi8< / sub>. CC (C)C[Si]12O[Si]3 (O[Si]4 (O[Si] (O1) (O[Si]5 (O[Si] (O2) (O[Si] (O3) (O[Si] (O4) (O5)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CCCS. CYGQPMMZQIQYKC-UHFFFAOYSA-N. 96%. | |
| Pss-(3-tosyloxypropyl)-heptaisobutyl su& | Pss-(3-tosyloxypropyl)-heptaisobutyl su&. Group: Poss nanohybrid materials. CAS No. 871126-43-1. Product ID: PSS-(3-Tosyloxypropyl)-heptaisobutyl substituted. Molecular formula: 1015.72346;g/mol. Mole weight: C38< / sub>H76< / sub>O15< / sub>SSi8< / sub>. CC (C)C[Si]12O[Si]3 (O[Si]4 (O[Si] (O1) (O[Si]5 (O[Si] (O2) (O[Si] (O3) (O[Si] (O4) (O5)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CCCOS (=O) (=O)C6=CC=CC=C6. ZEPRIVGTEZSIAC-UHFFFAOYSA-N. 96%. | |
| Pss-(4-(chloromethyl)phenyl))-heptacycl& | Pss-(4-(chloromethyl)phenyl))-heptacycl&. Uses: Designed for use in research and industrial production. Additional or Alternative Names: PSS-(4-(CHLOROMETHYL)PHENYL))-HEPTACYCL&;PSS-(4-CHLOROBENZYL)-HEPTACYCLOPENTYL S;1-(4-Chlorobenzyl)-3,5,7,9,11,13,15-heptacyclopentylpentacyclo[9.5.1.13,9.15,15.17,13]octasiloxane. Product Category: Nanoparticles & Nanopowders. CAS No. 307496-35-1. Molecular formula: C42H69ClO12Si8. Mole weight: 1026.14. Product ID: ACM307496351. Alfa Chemistry ISO 9001:2015 Certified. | |
| Pss-chloropropyl-heptaisobutyl substitu& | Pss-chloropropyl-heptaisobutyl substitu&. Group: Poss nanohybrid materials. Alternative Names: PSS-CHLOROPROPYL-HEPTAISOBUTYL SUBSTITU&; 1-CHLOROPROPYL-3,5,7,9,11,-ISOBUTYLPENTA-CYCLO-(9.5.1.1(3,9).)OCTASILOXANE, 97%; pss-chloropropyl-heptaisobutyl substituted; Chloropropylisobutyl-PSS,PSS-Chloropropyl-isobutylsubstituted,1-Chloropropyl-3,5,7,9,11,13. CAS No. 480438-84-4. Product ID: Chloropropylisobutyl-PSS. Molecular formula: 894.015. Mole weight: C31< / sub>H69< / sub>ClO12< / sub>Si8< / sub>. CC (C)C[Si]12O[Si]3 (O[Si]4 (O[Si] (O1) (O[Si]5 (O[Si] (O2) (O[Si] (O3) (O[Si] (O4) (O5)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CC (C)C)CCCCl. XVYCGZTZIHTXDL-UHFFFAOYSA-N. 96%. | |
| PSS-Chloropropyl-Heptaisobutyl substituted | 97%. Group: Silsesquioxanes: poss nanohybrids. | |
Our database is helping our users find suppliers everyday.
